Carl Byrnes
Stock Analyst at Northland Capital Markets
(0.50)
# 3,147
Out of 4,502 analysts
14
Total ratings
44.44%
Success rate
-11.33%
Average return
Main Sectors:
9 Stocks
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
COCH Envoy Medical | Initiates: Outperform | n/a | $2.19 | - | 1 | Dec 21, 2023 | |
AMRN Amarin Corporation | Maintains: Market Perform | $2 → $1.25 | $0.78 | +59.36% | 1 | Jul 19, 2023 | |
CDIO Cardio Diagnostics Holdings | Initiates: Outperform | $8 | $0.48 | +1,555.63% | 1 | May 22, 2023 | |
BWAY BrainsWay | Maintains: Outperform | $15 → $5 | $7.28 | -31.32% | 1 | Nov 17, 2022 | |
VTVT vTv Therapeutics | Maintains: Outperform | $60 → $80 | $23.70 | +237.55% | 3 | Aug 17, 2022 | |
MDXG MiMedx Group | Initiates: Outperform | n/a | $7.38 | - | 1 | Jul 26, 2021 | |
ESPR Esperion Therapeutics | Maintains: Market Perform | n/a | $2.34 | - | 4 | May 5, 2021 | |
AYTU Aytu BioPharma | Initiates: Outperform | n/a | $2.75 | - | 1 | Oct 22, 2018 | |
HRTX Heron Therapeutics | Initiates: Outperform | n/a | $3.15 | - | 1 | Sep 27, 2017 |
Envoy Medical
Dec 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $2.19
Upside: -
Amarin Corporation
Jul 19, 2023
Maintains: Market Perform
Price Target: $2 → $1.25
Current: $0.78
Upside: +59.36%
Cardio Diagnostics Holdings
May 22, 2023
Initiates: Outperform
Price Target: $8
Current: $0.48
Upside: +1,555.63%
BrainsWay
Nov 17, 2022
Maintains: Outperform
Price Target: $15 → $5
Current: $7.28
Upside: -31.32%
vTv Therapeutics
Aug 17, 2022
Maintains: Outperform
Price Target: $60 → $80
Current: $23.70
Upside: +237.55%
MiMedx Group
Jul 26, 2021
Initiates: Outperform
Price Target: n/a
Current: $7.38
Upside: -
Esperion Therapeutics
May 5, 2021
Maintains: Market Perform
Price Target: n/a
Current: $2.34
Upside: -
Aytu BioPharma
Oct 22, 2018
Initiates: Outperform
Price Target: n/a
Current: $2.75
Upside: -
Heron Therapeutics
Sep 27, 2017
Initiates: Outperform
Price Target: n/a
Current: $3.15
Upside: -